Barricaid EU Post Market Study for Primary Lumbar Disc Herniation

NCT01534065 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
45
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Intrinsic Therapeutics